Chemoinformaics analysis of Farnesyl-acetaldehyde
| Molecular Weight | 248.41 | nRot | 9 |
| Heavy Atom Molecular Weight | 220.186 | nRig | 4 |
| Exact Molecular Weight | 248.214 | nRing | 0 |
| Solubility: LogS | -4.465 | nHRing | 0 |
| Solubility: LogP | 6.452 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 47.8622 |
| nHD | 0 | BPOL | 28.9578 |
| QED | 0.304 |
| Synth | 2.936 |
| Natural Product Likeliness | 1.868 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.63 |
| Pgp-sub | 0.003 |
| HIA | 0.006 |
| CACO-2 | -4.614 |
| MDCK | 0.0000138 |
| BBB | 0.88 |
| PPB | 0.869154 |
| VDSS | 7.227 |
| FU | 0.0652479 |
| CYP1A2-inh | 0.8 |
| CYP1A2-sub | 0.156 |
| CYP2c19-inh | 0.33 |
| CYP2c19-sub | 0.277 |
| CYP2c9-inh | 0.258 |
| CYP2c9-sub | 0.886 |
| CYP2d6-inh | 0.239 |
| CYP2d6-sub | 0.102 |
| CYP3a4-inh | 0.286 |
| CYP3a4-sub | 0.155 |
| CL | 12.332 |
| T12 | 0.128 |
| hERG | 0.012 |
| Ames | 0.006 |
| ROA | 0.005 |
| SkinSen | 0.978 |
| Carcinogencity | 0.738 |
| EI | 0.973 |
| Respiratory | 0.227 |
| NR-Aromatase | 0.064 |
| Antiviral | Yes |
| Prediction | 0.773138 |